# Tris Pharma Pays Texas $7.5 Million

> Texas AG settles $7.5m lawsuit with Tris Pharma over ADHD drug claims.
- Title: Tris Pharma Pays Texas $7.5 Million · Dallas Express
- Summary: Texas AG settles $7.5m lawsuit with Tris Pharma over ADHD drug claims. Tris Pharma agreed to pay Texas $7.5 million after misleading claims about ADHD…
- Keywords: tris pharma, texas, attorney general, dyanavel xr, adhd, medicaid, settlement, pharmaceutical, news, politics, Tris, Pharma
- Source: Dallas Express — https://dallasexpress.com/state/tris-pharma-to-pay-texas-7-5-million-over-alleged-misleading-adhd-drug-claims
- Author: Dallas Express
- Published: 2026-10-02T11:00:00+00:00
- Read time: 1 min
- Topics: tris pharma, texas, attorney general, dyanavel xr, adhd, medicaid, settlement, pharmaceutical, news, politics
## Settlement Announcement
Texas Attorney General Ken Paxton reached a $7.5 million settlement with Tris Pharmaceuticals over allegations of misleading ADHD drug claims.
## Alleged Misleading Claims
Tris Pharma overstated Dyanavel XR's effectiveness and instructed sales reps to claim it worked faster than competitors with unproven benefits for children.
## Settlement Details
The agreement resolves claims that Tris Pharma misrepresented Dyanavel XR's effectiveness to Texas Medicaid providers through false statements.
## Attorney General Statement
Paxton stated Tris Pharma is paying millions for misleading folks about ADHD drugs prescribed to children and will continue protecting Texas children.
## Settlement Terms
The agreement includes mutual desire to settle amicably and avoids litigation costs while defendants deny all liability and wrongdoing.
## Key takeaway

Tris Pharma agreed to pay Texas $7.5 million after misleading claims about ADHD medication effectiveness.